ERVW-1 and HIV-1 infection: If the measured Env-gp120 distances reflect the distances of the transmitted viruses (which cannot be empirically verified from HVTN 505 data as noted in the Introduction), then these findings suggest that the vaccine may have selectively blocked HIV-1 infection when Env-gp120, especially in the CD4bs region, was close to the vaccine sequence.